These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33445991)

  • 1. Physiologic and hemodynamic changes in patients undergoing open abdominal cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    Kim MH; Yoo YC; Bai SJ; Lee KY; Kim N; Lee KY
    J Int Med Res; 2021 Jan; 49(1):300060520983263. PubMed ID: 33445991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Global End-Diastolic Volume (GEDV) Could Be More Appropiate to Fluid Management Than Central Venous Pressure (CVP) During Closed Hyperthermic Intrabdominal Chemotherapy with CO
    Redondo FJ; Padilla D; Villarejo P; Baladron V; Faba P; Sánchez S; Muñoz-Rodríguez JR; Bejarano N
    J Invest Surg; 2018 Aug; 31(4):321-327. PubMed ID: 28557569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of bioreactance and pulse power analysis in measuring cardiac index during cytoreductive abdominal surgery with hyperthermic intraperitoneal chemotherapy (HIPEC).
    Ylikauma LA; Tuovila MJ; Ohtonen PP; Erkinaro TM; Vakkala MA; Takala HT; Liisanantti JH; Kaakinen TI
    BMC Anesthesiol; 2023 Jan; 23(1):38. PubMed ID: 36721097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic and respiratory implications of high intra-abdominal pressure during HIPEC.
    Reis ACV; Kusamura S; Azmi N; Fumagalli L; Piccioni F; Valenza F; Baratti D; Guaglio M; Cavalleri A; Garrone G; Barretta F; Deraco M
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1896-1901. PubMed ID: 32147425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perianesthesia Measurement During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Procedure: A Case Report and Review of the Literature.
    Li D; Henker R; Zhang F
    J Perianesth Nurs; 2019 Feb; 34(1):198-205. PubMed ID: 29685726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic Monitoring During Heated Intraoperative Intraperitoneal Chemotherapy Using the FloTrac/Vigileo System.
    Mavroudis C; Alevizos L; Stamou KM; Vogiatzaki T; Eleftheriadis S; Korakianitis O; Tentes AA; Iatrou C
    Int Surg; 2015 Jun; 100(6):1033-9. PubMed ID: 25590363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.
    Wu HT; Yang XJ; Huang CQ; Sun JH; Ji ZH; Peng KW; Zhang Q; Li Y
    World J Surg Oncol; 2016 Sep; 14(1):246. PubMed ID: 27633880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-abdominal pressure, Cardiac Index and vascular resistance during hyperthermic intraperitoneal chemotherapy: a prospective observational study.
    Schluermann CN; Hoeppner J; Benk C; Schmidt R; Loop T; Kalbhenn J
    Minerva Anestesiol; 2016 Feb; 82(2):160-9. PubMed ID: 25971283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four different methods of measuring cardiac index during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Heijne A; Krijtenburg P; Bremers A; Scheffer GJ; Malagon I; Slagt C
    Korean J Anesthesiol; 2021 Apr; 74(2):120-133. PubMed ID: 32819047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Goal-directed therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a prospective observational study.
    Esteve-Pérez N; Ferrer-Robles A; Gómez-Romero G; Fabián-Gonzalez D; Verd-Rodriguez M; Mora-Fernandez LC; Segura-Sampedro JJ; Tejada-Gavela S; Morales-Soriano R
    Clin Transl Oncol; 2019 Apr; 21(4):451-458. PubMed ID: 30218305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study.
    Yu P; Ye Z; Dai G; Zhang Y; Huang L; Du Y; Cheng X
    BMC Cancer; 2020 Nov; 20(1):1108. PubMed ID: 33198674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
    Berger Y; Aycart S; Mandeli JP; Heskel M; Sarpel U; Labow DM
    Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Coagulation in Cancer Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Treatment (HIPEC)-A Systematic Review.
    Lundbech M; Damsbo M; Krag AE; Hvas AM
    Semin Thromb Hemost; 2024 Apr; 50(3):474-488. PubMed ID: 36828005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin.
    Cravioto-Villanueva A; Cavazos M; Luna-Perez P; Martinez-Gomez H; Ramirez ML; Solorzano J; Montiel H; Esquivel J
    Surg Today; 2016 Aug; 46(8):979-84. PubMed ID: 27138212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel prognostic score for outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with metachronous peritoneal carcinomatosis.
    Chin KM; Tan GHC; Chia CS; Ong JCA; Teo MCC
    ANZ J Surg; 2020 Oct; 90(10):1958-1964. PubMed ID: 32159299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enterocutaneous fistula in patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Incidence, management and outcomes.
    Valle SJ; Alzahrani N; Alzahrani S; Traiki TB; Liauw W; Morris DL
    Surg Oncol; 2016 Sep; 25(3):315-20. PubMed ID: 27566038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25-year experience.
    Nikiforchin A; Gushchin V; King MC; Baron E; Nieroda C; Sittig M; Sardi A
    J Surg Oncol; 2021 Mar; 123(4):1030-1044. PubMed ID: 33524164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II).
    Koemans WJ; van der Kaaij RT; Boot H; Buffart T; Veenhof AAFA; Hartemink KJ; Grootscholten C; Snaebjornsson P; Retel VP; van Tinteren H; Vanhoutvin S; van der Noort V; Houwink A; Hahn C; Huitema ADR; Lahaye M; Los M; van den Barselaar P; Imhof O; Aalbers A; van Dam GM; van Etten B; Wijnhoven BPL; Luyer MDP; Boerma D; van Sandick JW
    BMC Cancer; 2019 May; 19(1):420. PubMed ID: 31060544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Best practice for perioperative management of patients with cytoreductive surgery and HIPEC.
    Raspé C; Flöther L; Schneider R; Bucher M; Piso P
    Eur J Surg Oncol; 2017 Jun; 43(6):1013-1027. PubMed ID: 27727026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy, Part I: Introduction and Indications.
    Dunn D
    AORN J; 2019 Nov; 110(5):479-499. PubMed ID: 31660604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.